Sars Medicaments Private Limited - Company Profile

It is a business services private limited company based in Bangalore North, Karnataka, India, established in 2025.
2025 Bangalore North, Karnataka, India Active
Last Updated:
Access Report
About Sars Medicaments Private Limited

Sars Medicaments Private Limited, a active private limited company, was established on 21 February 2025 in Bangalore North, Karnataka, India. it holds CIN: U46497KA2025PTC198417. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Karuna Softa (Director), Sumy Agrawal (Director). Past directors included Sunil Kumar Sundrani. It is based at G3 Iris Block Sonesta Cos, Mos 13 Cross Maruti Nagar, Bangalore North, Karnataka, 560075.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497KA2025PTC198417

  • Registration Number

    198417

  • Incorporation Date

    21 February 2025

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 9 Days
Company report

Sars Medicaments Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sars Medicaments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sars Medicaments Private Limited?
Current Directors
Name Designation Appointment Date Status
Karuna Softa Director 21 Feb 2025 Current
Sumy Agrawal Director 21 Feb 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Sep 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sars Medicaments.
Sars Medicaments revenue growth over time
Sars Medicaments profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sars Medicaments?

Unlock access to Sars Medicaments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sars Medicaments?

Unlock and access historical data on people associated with Sars Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sars Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sars Medicaments's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sars Medicaments
Recent Activity within the Organization
  • Director Appointment

    Progress on Karuna Softa was appointed as a Director was appointed as a Director on 21 Feb 2025 & has been associated with this company since 1 year 9 days . was documented.

  • Director Appointment

    Progress on Sumy Agrawal was appointed as a Director was appointed as a Director on 21 Feb 2025 & has been associated with this company since 1 year 9 days . was documented.

  • Company Incorporation

    Sars Medicaments Private Limited was registered on 21 Feb 2025 with Roc Bangalore & aged 1 year 9 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sars Medicaments Private Limited?

The CIN of Sars Medicaments Private Limited is U46497KA2025PTC198417.

Where is Sars Medicaments Private Limited headquartered?

Sars Medicaments Private Limited is headquartered at G3 Iris Block Sonesta Cos, Mos 13 Cross Maruti Nagar, Bangalore North, Karnataka, 560075.

When was Sars Medicaments Private Limited incorporated?

Sars Medicaments Private Limited was incorporated on 21 February 2025.

Who are the current directors of Sars Medicaments Private Limited?

The current directors of Sars Medicaments Private Limited are

Is Sars Medicaments Private Limited a listed company?

Sars Medicaments Private Limited is unlisted.

What is the capital structure of Sars Medicaments Private Limited?

The authorized capital of Sars Medicaments Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available